Exposed: secrets of the animal organ lab
Scientists' success in Cambridgeshire
could have saved thousands of lives. But they failed, animals suffered and the truth was covered up, reports
Mark Townsend
The Observer
Amid the rolling fields of Cambridgeshire stands a
sprawling complex, protected by barbed wire and an army of security guards.
Beyond the wire is a maze of laboratories where scientists work to find cures
for the suffering of mankind.
This is
Today The Observer can
expose the previously hidden world of vivisection. A huge volume of
confidential documents - the largest-ever set of data concerning animal
experiments in the UK - has finally been released following the defeat earlier
this month of an injunction imposed by drug companies 30 months ago. These
documents chart the race to supply an unlimited supply of animal organs in a
bid to save the lives of thousands of Britons.
The quest for a successful programme of xenotransplantation
- in which genetically modified animal orrgans are used within humans - remains
the scientific equivalent of the holy grail. The
rewards for success will be huge: analysts predict that a market worth £6
billion a year awaits the first firm which can prevent the rejection of such
organs when used in humans.
Little wonder that
scientists, giant drug companies and Government Ministers have been committed
to pouring millions of pounds into the HLS programme.
So has it been worth it?
To the dismay of animal
rights activists, the documents reveal how primates were used in the search for
a solution to the chronic global shortage of human organs for transplant.
Baboons were transported from the African savannahs to die in steel cages the
size of toilet cubicles. The documents show that a quarter of the primates died
from 'technical failures'.
Researchers describe how
monkeys and baboons died in fits of vomiting and diarrhoea.
Symptoms included violent spasms, bloody discharges, grinding teeth and
uncontrollable, manic eye movements. Other animals retreated within themselves,
lying still in their cages until put of their misery.
Baboon W201m died of a
stroke after two days of suffering from limb spasms and paralysis. Baboon W205m
was 'sacrificed' after 21 days. A genetically modified pig's heart had been
welded to the vital arteries within its neck. Researchers noted the heart was
swelling way beyond its natural size. Strange yellow fluid was seen seeping
from the organ.
Others never even made it
to HLS, suffering painful deaths en route. Faxes from global wildlife dealers
reveal how at least 50 baboons were taken from the African plains for the
experiments. In one shipment the creatures spent 34 hours in cramped transport
crates - 10 hours longer than approved by the Home Office, which chose not to
take any action.
In another shipment, three
monkeys were found dead with blood oozing from their nostrils at a
The Government's
involvement in the xenotransplantation programme - the most high-profile animal experimentation
ever conducted in
Many of the 1,274 pages of
documents reveal a litany of failings that will serve to ignite further
controversy over HLS, which last week won a ground-breaking injunction preventing
animal protesters getting close to employees' homes. Fundamental questions over
the value of vivisection itself will also be asked.
The papers reveal attempts
to bury the true extent of animal suffering from experiments conducted at the
HLS laboratories between 1994 and 2000. Serious incidents of unlicensed animals
suffering were not adequately investigated and regulations were not enforced
properly.
Breaches of the law even
went unpunished in some cases, with the Home Office limiting itself to letters
of 'admonishment'. One previously confidential paper reveals how the Home
Office worked with Imutran - the former British
subsidiary of multi-million drug giant Novartis,
which was in control of the programme - to
underestimate the suffering caused by the most severe experiments.
An Imutran
report states: 'The Home Office will attempt to get the kidney transplants
classified as "moderate", ensuring that it is easier for Imutran to receive a licence and
ignoring the "severe" nature of these programmes.'
The truth of what has been
happening at HLS can now be revealed because of a historic legal victory. The
verdict represents an extraordinary triumph for a Sheffield-based animal rights
group, Uncaged Campaigns, which defeated the
injunction imposed by Imutran and Novartis
to suppress the release of the documents. The group successfully argued that
the issue was one of overwhelming public interest on a highly sensitive area of
policy.
Dan Lyons has spent the
past two-and-a-half years battling against some of
For the scientists
involved, the failure of the project to overcome the human body's natural
rejection of foreign organs such as hearts and kidneys is the real tragedy.
Last year 6,482 people in
Novartis yesterday defended its role at HLS
by arguing that developing new cures for humans invariably meant experimenting
on live animals.
The documents refer to the
transplanting of genetically modified pigs' hearts and kidneys into monkeys.
Throughout the Nineties, Imutran claimed it was on
the cusp of solving the crucial issue of organ rejection, which has prevented
trials on humans. In 1995 it told the world it would be ready to start
transplanting pig hearts into humans within a year. Yet the documents clearly
show that the company's xenotransplantation programme has come nowhere near to fulfilling its promises.
Imutran finally left the HLS site in 2000 -
and then won an injunction to prevent details of the failed xenotransplantation
project coming to light.
An internal inquiry
recorded that Imutran and the Home Office admitted
that the crates breached size and ventilation regulations. Elsewhere,
government officials reassured Imutran on several
occasions that a crucial meeting to discuss new licence
applications would be a 'rubber-stamping' exercise.
Other striking findings
reveal that the Government approved Imutran's xenotransplanation experiments with the intention of using
sick babies as the first trial patients for animal heart transplants.
Some of the research was
personally authorised by Ministers, who have rejected
calls for an independent judicial inquiry.
In total, the documents
reveal at least 520 errors and omissions in the Imutran
research. These include organ weights not being recorded, a quadruple overdose,
conflicting pathology reports and re-use of animals. One primate was killed
when a swab was left inside it.
Rather than admit defeat,
however, Imutran - now defunct - made a number of
inaccurate claims regarding the success of experiments, effectively
exaggerating the results of its tests to increase the likelihood of new licences being granted.
A Novartis
spokesman admitted that Imutran had reported 'several
significant' mistakes to the Home Office but said the company was committed to
ensuring similar mistakes would never be repeated. And the company remains
convinced that its quest to solve the world's organ shortage will one day be realised.
Three centuries
searching for the holy grail
The strange history of
animal-to-human transplants, known as xenotransplantation,
goes back to 1682, when the bone from a dog was used to repair the skull of an
injured Russian aristocrat. It worked.
Heart transplant pioneer
Christian Barnard did experimental work on baboons' hearts in
In 1963, surgeon Thomas Starzl grafted baboon kidneys into six patients. They
survived between 19 and 98 days.
The advent of cyclosporin, an immunosuppressant drug, gave researchers a
greater chance of success. In 1977 a 25-year-old woman was given a baboon heart
in
In 1984, a newborn baby
received a baboon heart in
Nine years later, baboon
bone marrow and a kidney transplant was carried out in
In 1997, Dolly the Sheep
was cloned in
Scientists realised the risk that viruses from an animal could be
transmitted to people. The Government announced it was regulating xenotransplantation.
The prospect of the biotech
companies earning millions from xenotransplantation
began to diminish. Companies such as PPL Therapeutics reported losses.
In 2002, science turned to
stem cell research. These cells can be engineered to grow new organs with the
right genetic make-up, instead of needing animal organs.
http://www.observer.co.uk/uk_news/story/0,6903,940033,00.html